Blues TEC Issues Negative Review Of Cyberonics’ VNS Therapy For Depression

The BlueCross BlueShield Association's Technology Evaluation Center (TEC) says there is insufficient evidence to conclude that Cyberonics' VNS Therapy improves net health outcomes of patients with treatment-resistant depression

More from Archive

More from Medtech Insight